Related Experiment Video
Updated: Aug 10, 2025
06:54
Evaluation of the Interplay Between the Complement Protein C1q and Hyaluronic Acid in Promoting Cell Adhesion
Published on: June 15, 2019
6.1K
Hyaluronan in the Cancer Cells Microenvironment
Evgenia Karousou1, Arianna Parnigoni1, Paola Moretto1
1Department of Medicine and Surgery, University of Insubria, 21100 Varese, Italy.
Cancers
|February 11, 2023
Summary
Hyaluronan, a molecule in the extracellular matrix, significantly impacts cancer progression and patient outcomes. Understanding and modulating its metabolism is crucial for developing effective cancer therapies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Hyaluronan (HA) is a glycosaminoglycan synthesized by various cells, including macrophages, tumor cells, and stromal cells.
- Changes in HA concentration and size alter tissue stiffness and cellular responses via plasma membrane receptors.
- HA influences key cancer cell behaviors: apoptosis evasion, unlimited replication, angiogenesis, and metastasis.
Purpose of the Study:
- To explore the multifaceted role of hyaluronan in cancer progression.
- To investigate the regulatory mechanisms of hyaluronan metabolism in cancer.
- To identify potential therapeutic targets for modulating hyaluronan in cancer treatment.
Main Methods:
- Review of existing literature on hyaluronan synthesis, degradation, and function in cancer.
- Analysis of how cellular and environmental factors influence hyaluronan metabolism.
- Exploration of potential therapeutic strategies targeting hyaluronan.
Main Results:
- Hyaluronan concentration and dimensions are critical for tumor progression and patient prognosis.
- Hyaluronan metabolism is influenced by growth factors, inflammation, and cellular metabolic state.
- Current therapeutic strategies targeting hyaluronan are limited, necessitating further investigation into side effects and novel targets.
Conclusions:
- Modulating hyaluronan metabolism presents a complex but promising avenue for cancer therapy.
- Further research is needed to identify upstream regulators and secreted factors for targeted interventions.
- Co-culture systems involving cancer, fibroblasts, and immune cells may reveal new therapeutic targets.
Related Concept Videos
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
02:53Adaptive Mechanisms in Cancer Cells
5.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K
01:35Cancer Cell Migration through Invadopodia
2.4K
Invadosome is a broad category of cell surface structures with proteolytic activity that degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
2.4K
02:40Cancer Stem Cells and Tumor Maintenance
5.0K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
5.0K
01:20Cell Adhesion Molecules - Types and Functions
6.9K
Cell adhesion molecules (CAMs) are pivotal to multicellularity and the coordinated functioning of tissues and organ systems. They enable physical interactions between cells and provide mechanical strength to tissues. They also function as receptors for signal transmission across the plasma membrane. The CAMs are broadly classified into four families - integrins, cadherins, selectins, and immunoglobulin-like CAMs (IgCAMs).
CAM Families
The Integrin family of proteins is primarily involved...
CAM Families
The Integrin family of proteins is primarily involved...
6.9K
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K